Studies in Preparation and Evaluation of pH-Independent Sustained-Release Matrix Tablets of Verapamil HCI Using Directly Compressible Eudragits

Pharmaceutical Development and Technology

Volumn 8, Issue 4, 2003, Pages 323-333

  Gohel, Mukesh C ^a   Patel, Tejas P ^a   Bariya, Shital H ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Direct compression; Eudragit RL PO; Eudragit RS PO; Hydrophilic matrix; Similarity factor (f2); Swelling study, pH independent drug release

Indexed keywords

EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 4000; SUCCINIC ACID; VERAPAMIL;

ARTICLE; BIOCOMPATIBILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; MATRIX TABLET; MULTIPLE REGRESSION; POLYMERIZATION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; TABLET COMPRESSION; TABLET MANUFACTURE;

BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; HYDROGEN-ION CONCENTRATION; POLYMETHACRYLIC ACIDS; PRESSURE; TABLETS; VERAPAMIL;

EID: 0142094562     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120024686     Document Type: Article

References (15)

1. Khan, M.A.; Reddy, I.K. Controlled drug delivery-development of solid oral dosage forms with acrylate polymers. STP Pharm. Sci. 1997, 7 (6), 483-490.
2. Dittgen, M.; Durrani, M.; Lehmann, K. Acrylic polymers-a review of pharmaceutical applications. STP Pharm. Sci. 1997, 7 (6), 403-437.
3. Dimitrov, M.; Lambov, N. Study of verapamil hydrochloride release from compressed hydrophilic Polyox-Wsr tablets. Int. J. Pharm. 1999, 189 (1), 105-111.
4. Loggia, N.; Roe, C.; Kohya, S.; Smith, J.S.; Macrae, R.J. Low shear aqueous granulation of a hydrophilic matrix tablet formulation containing a high polymer content. J. Pharm. Pharmacol. 1999, 51 (Supplement), 309.
5. Streubel, A.; Siepmann, J.; Dashevsky, A.; Bodmeier, R. pH-independent release of a weakly basic drug from water-insoluble and water-soluble matrix tablets. J. Con. Rel. 2000, 67 (1), 101-110.
6. Siepmann, J.; Lecomte, F.; Bodmeier, R. Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. J. Con. Rel. 1999, 60 (2-3), 379-389.
7. Wade, A.; Weller, P.J. Polyethylene glycol. In Handbook of Pharmaceutical Excipients, 4th Ed.; The Pharmaceutical Press: London, 1994; 355-357.
8. Sujja-areevath, J.; Munday, D.L.; Cox, P.J.; Khan, K.A. Relationship between swelling, erosion and drug release in hydrophilic natural gum minimatrix formulations. Eur. J. Pharm. Sci. 1998, 6 (3), 207-217.
9. Mulye, N.V.; Turco, S.J. Matrix type tablets formulation for controlled release of highly water soluble drugs. Drug Dev. Ind. Pharm. 1994, 20 (17), 2633-2643.
10. Bamba, M.; Puisienusx, F.; Marty, J.P.; Cartensen, J.T. Release mechanisms in gel forming sustained release preparations. Int. J. Pharm. 1979, 2, 307-315.
11. Mendenhall, W.; Sincich, T. In A Second Course in Business Statistics: Regression Analysis, 3rd Ed.; Dellen Publishing Co.: California, 1989; 141-226.
12. Gohel, M.C.; Jani, G.K.; Amin, A.F.; Patel, K.V.; Gupta, S.V. Application of classical experimental design for the development of theophylline microspheres. J. Con. Rel. 1997, 45 (3), 265-271.
13. Moore, J.W.; Flanner, H.H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 20 (6), 64-74.
14. 2. Pharm. Res. 1998, 15 (6), 889-896.
15. Patel, K.V. Studies in design and characterization of controlled release antihypertensive drug formulations prepared using bio-compatible polymers. Ph.D. Thesis; L.M. College of Pharmacy, Gujarat University, 1998-1999.